Indian pharma stocks surge as generic drugmakers exempted from U.S. tariff, boosting Nifty Pharma shares and industry outlook ...

Other names on the Nifty Pharma index that has a significant upside potential include Aurobindo Pharma and Ajanta Pharma, both of which have an upside potential of 23%.

Indian equities brace for a roller coaster session on Thursday, April 3, as US President Donald Trump, in the early hours of ...

It’s a party for pharma stocks on Dalal Street. The Nifty Plarma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA ...

AM, all 20 Nifty Pharma constituents traded in the green. Among others, Gland Pharma was up 7.74 per cent, Lupin was up over ...

India pharmaceutical stocks soared today after US President Donald Trump imposed a 26% reciprocal tariff on India but excluded the pharma sector from the levies.

The Delhi High Court on Monday dismissed an interim injunction application filed by Swiss pharmaceutical giant F Hoffmann-La ...

The bench said that public good outweighs the company’s profit as the drug is not available at an affordable price in India.

The high court noted that SMA is a debilitating disease which has no cure, and the only approved drug, Risdiplam, marketed ...

In a major relief to Indian drugmaker Natco Pharma, the Delhi High Court has rejected an interim injunction plea filed by ...

The Delhi High Court denied Roche's request to temporarily restrain Natco Pharma from producing its spinal muscular atrophy ...